Trial Profile
A randomized, open-label, placebo-controlled trial to investigate the kinetics of the immune responses elicited by a liquid formulation of influenza virus vaccine, trivalent, types A & B, live, cold-adapted (CAIV-T) in healthy adults aged 18 to <65 years
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors MedImmune
- 31 Oct 2006 Status change
- 19 Jan 2006 New trial record.